Literature DB >> 4831323

Treatment of Paget's disease of bone with synthetic human calcitonin: biochemical and roentgenologic changes.

P B Greenberg, F H Doyle, M T Fisher, C J Hillyard, G F Joplin, J Pennock, I MacIntyre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4831323     DOI： 10.1016/0002-9343(74)90816-x

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  14 in total

1.  Medical staff conference. Paget disease of bone.

Authors: 
Journal:  West J Med       Date:  1978-09

Review 2.  Treatment of patients with Paget's disease of bone.

Authors:  C Roux; M Dougados
Journal:  Drugs       Date:  1999-11       Impact factor: 9.546

Review 3.  Medicine in the elderly.

Authors:  P Diggory; A Homer; J Liddle; C F Pratt; S Samadian; R Tozer; C Weinstein
Journal:  Postgrad Med J       Date:  1991-05       Impact factor: 2.401

4.  The effect of high-dose salmon calcitonin on bone mineral metabolism in the normal rat.

Authors:  N Glajchen; S Thomas; P Jowell; S Epstein; F Ismail; M Fallon
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

Review 5.  Treating Paget's disease.

Authors:  D A Heath
Journal:  Br Med J (Clin Res Ed)       Date:  1987-04-25

6.  Paget's disease of bone.

Authors:  E S Siris; T P Jacobs; R E Canfield
Journal:  Bull N Y Acad Med       Date:  1980-04

7.  Prevention of osteoporosis with nasal salmon calcitonin: effect of anti-salmon calcitonin antibody formation.

Authors:  J Y Reginster; S Gaspar; R Deroisy; B Zegels; P Franchimont
Journal:  Osteoporos Int       Date:  1993-09       Impact factor: 4.507

8.  Endogenous production of specific antibodies does not decrease hypocalcemic response to calcitonin in young rabbits.

Authors:  J Y Reginster; M Azria; S Gaspar; M Bleicher; N Franchimont; M Behhar; A Albert; P Franchimont
Journal:  Calcif Tissue Int       Date:  1992-06       Impact factor: 4.333

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Response of Paget's disease to human calcitonin in patients resistant to porcine calcitonin.

Authors:  V Lo Cascio; S Adami; G Galvanini; R Lazzaretto; M Ferrari; D Tartarotti; L A Scuro
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.